INITIATING HCV TREATMENT WITH DIRECT ACTING AGENTS IN OPIOID AGONIST TREATMENT: WHEN TO START FOR PEOPLE CO-INFECTED WITH HIV?

BACKGROUND: Direct acting antivirals (DAA) raise the possibility of eliminating Hepatitis C virus (HCV) among people who inject drugs (PWID). However, concerns regarding treatment retention and reinfection challenge implementation efforts. Opioid agonist treatment (OAT) provides an opportunity to en...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Drug Policy
Hauptverfasser: Panagiotoglou, Dimitra, Krebs, Emanuel, Min, Jeong Eun, Olding, Michelle, Ahamad, Keith, Ti, Lianping, Montaner, Julio S.G., Nosyk, Bohdan
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5798603/
https://ncbi.nlm.nih.gov/pubmed/28578865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2017.05.021
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge